Cone Beam CT Scanning in Lung and Bladder Cancer.

February 23, 2016 updated by: AHS Cancer Control Alberta

Improving the Accuracy of Radiotherapy Planning and Delivery Using Kilovoltage Cone Beam CT Imaging

To study changes in tumor and normal organ size and/or position which occur during a course of radiation treatments.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Canada
- Alberta
  - Edmonton, Alberta, Canada
    - Cross Cancer Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

primary care clniic

Description

Inclusion Criteria:

Patient has biopsy proven limited stage SCLC
receiving radical concurrent chemoradiotherapy
no prior chest RT
no prior surgical resection of lung tumor
no prior chemotherapy
patients' lung tumors should be centrally-located to minimize the effect of respiratory motion
patient has biopsy proven TCC bladder
receiving radical concurrent chemoradiotherapy or RT alone
no prior chemotherapy
patient signs study-specific consent form

Exclusion Criteria:

mixed small cell and non small cell histology
patient not being treated with concurrent chemoradiotherapy
chemoradiotherapy given sequentially
previous chest RT
previous chemotherapy
prior surgical resection of lung mass
patient ineligible for pelvic RT
patient does not sign study consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AHS Cancer Control Alberta

Collaborators

Cross Cancer Institute

Investigators

Principal Investigator: Don Yee, MD, AHS Cancer Control Alberta

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2007

Primary Completion (Actual)

August 1, 2009

Study Completion (Actual)

April 1, 2010

Study Registration Dates

First Submitted

May 2, 2007

First Submitted That Met QC Criteria

May 2, 2007

First Posted (Estimate)

May 4, 2007

Study Record Updates

Last Update Posted (Estimate)

February 24, 2016

Last Update Submitted That Met QC Criteria

February 23, 2016

Last Verified

December 1, 2011

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

LU-11-0073

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.